2018-02-11 07:30:00 Sun ET
technology social safety nets education infrastructure health insurance health care medical care medication vaccine social security pension deposit insurance
President Trump unveils his ambitious $1.5 trillion public infrastructure plan. Trump proposes offering $100 billion in federal incentives to encourage states and cities to invest in roads, bridges, highways, railways, and water utilities etc. The federal incentives help spur $1.5 trillion infrastructure expenditures over the next decade. Transportation Secretary Elaine Chao indicates to the House Transportation and Infrastructure Committee that the Trump team seeks to work with Congress to find bipartisan solutions. All options are on the table, and the Trump administration is open to considering all revenue sources.
This plan calls for allocating at least $200 billion in initial federal funds to encourage states, cities, and the private sector to spur $1.5 trillion infrastructure expenditures over the next decade. Also, this plan would reduce the amount of time for issuing onsite construction permits for infrastructure projects to 2 years.
Since his presidential election victory, Trump has thus far focused on bilateral trade, healthcare, immigration, gun control, and other socioeconomic issues. There may or may not be enough time for passing an infrastructure bill in late-2018.
U.S. lawmakers may need to act fast during a lame-duck interim session after the November 2018 midterm elections.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2018-12-23 13:39:00 Sunday ET
The House of Representatives considers a government expenditure bill with border wall finance and therefore sets up a shutdown stalemate with Senate. As fre
2023-01-03 09:34:00 Tuesday ET
USPTO fintech patent protection and accreditation As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2022-03-05 09:27:00 Saturday ET
Addendum on empirical tests of multi-factor models for asset return prediction Fama and French (2015) propose an empirical five-factor asset pricing mode
2026-02-02 12:30:00 Monday ET
With U.S. fintech patent approval, accreditation, and protection for 20 years, our proprietary alpha investment model outperforms most stock market indexes
2018-05-06 07:30:00 Sunday ET
President Trump withdraws America from the Iran nuclear agreement and revives economic sanctions on Iran for better negotiations as western allies Britain,